|
 In the 30-day experiment, researchers gave 11 patients daily
morphine pills and 10 people placebos and then took magnetic
resonance imaging (MRI) scans to see if treatment impacted the
brain.
The morphine group had gray matter volume declines of about 3
percent in regions of the brain thought to regulate emotions,
cravings and responses to pain and volume increases in areas
believed to be responsible for learning, memory and executive
function. No changes occurred with the placebo.
“Because we are seeing that opioids rapidly change the brain, our
take-home message is that opioids should be reserved for cases when
most other treatment options have failed,” said lead study author
Dr. Joanne Lin, a researcher at the University of Alabama at
Birmingham.
While more research is still needed to understand how opioids may
alter the brain and whether these shifts in gray matter are harmful,
caution is still warranted because the medicines can be addictive
and lead to abuse and overdose deaths, Lin added by email.
“We know that some people become addicted, but we don’t really know
why – or how to stop it,” Lin said. “By examining brain changes, we
may be able to identify targets to prevent adverse opioid events.”
While animal research has linked long-term opioid use to changes in
the brain, the current study offers fresh insight into how even
short-term use of the drugs may alter the human brain, Lin and
colleagues note in the journal Pain Medicine.
Patients in the current study had been suffering from chronic back
pain for around eight years on average, and none of them had a
history of drug abuse or opioid use.
The patients experienced similar rates of pain reduction whether
they got morphine or a placebo, though all of them were allowed to
take over-the-counter pain drugs during the study period.
Among people in the morphine group, gray matter volume decreased in
several reward-processing regions, such as the gyrus rectus, which
regulates learning and memory, and the insula, an area involved in
cravings.
Shrinkage in the left dorsal posterior cingulate, involved in pain
processing, was significantly associated with morphine consumption,
and higher doses of the opioid pill were tied to larger volume
changes in this part of the brain.
Significant volume loss was also seen in the amygdala, an area
central to emotional responses such as fear, anger, pleasure and
pain, as well as being involved in impulse control, addiction and
tolerance.
[to top of second column] |
For morphine users, gray matter volume also increased in regions
located outside reward-processing networks, such as in the cingulate
cortex, which is involved many functions, including pain responses
and learning.
In addition to the study’s small size, another limitation is that
the age and gender makeup was markedly different between the two
groups, the authors note. Researchers also didn’t ask people on
placebo if they thought they were taking morphine, so they cannot
know if the participants’ beliefs affected shifts in brain volume.
While doctors should still weigh the potential negative consequences
of opioid use before prescribing these drugs, the study findings on
their own don’t provide enough evidence to suggest physicians should
change how they treat pain, said Laura Stone, a researcher at McGill
University in Montreal who wasn’t involved in the new research.
Often, a combination of physical therapy and medication may be best
for back pain, Stone added by email. Exercise, yoga, meditation and
a healthy diet may ease discomfort and also have the potential to
address problems that can accompany back pain such as depression and
anxiety.
“Morphine and other similar opioid drugs provide excellent pain
relief in many individuals, especially for short treatment periods,
and can result in real improvements in quality of life,” Stone said.
“Concerns about the negative consequences of long-term use must be
balanced for each individual against the potential therapeutic
benefits.”
SOURCE: http://bit.ly/1mYLxEK Pain Medicine, online December 26,
2015.
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
